Defined Health's 7th Annual Therapeutic Insight Conference is 'Back in Town'; Speakers Announced and Registration Open

MORRISTOWN, N.J., Dec. 5 /PRNewswire/ -- Defined Health has announced the preliminary agenda and invited and confirmed speakers for its 7th annual Therapeutic Insight Conference. Therapeutic Insight 2007 ("TI2007") will take place on April 25 and 26, 2007, at the InterContinental The Barclay New York. The agenda and registration information along with content and attendee statistics from prior Therapeutic Insight conferences is available on the conference website, at http://www.therapeuticinsight.com/.

TI2007 will feature a distinguished roster of senior industry decision makers and key opinion leading clinicians, including:

  - Mara G. Aspinall, President, Genetics, Genzyme Corporation
    Karen Bernstein, PhD, Chairman & Editor-in-Chief, BioCentury
    Publications
  - Claudio Carini, MD, PhD, FRCPath, VP Translational Medicine, Development
    & Regulatory Services, MDS Pharma Services
  - Michael D. Clayman, MD, Vice President, Lilly Research Laboratories
  - Ron Cohen, MD, President, Chief Executive Officer, Founder & Director,
    Acorda Therapeutics, Inc.
  - Kapil Dhingra, PhD, VP Medical Science, Roche
  - Richard DiMarchi, PhD, Professor of Chemistry, Linda and Jack Gill Chair
    in Biomolecular Sciences, Indiana University
  - Jean Fourcroy, MD, PhD, MPH, Consultant on Urology, Endocrinology and
    Regulatory Issues
  - Frederick Frank, Vice Chairman, Lehman Brothers
  - Alexandre de Germay, Worldwide Commercial Head, Urology, Gynecology &
    Sexual Health, Pfizer Inc.
  - Geoffrey Ginsburg, MD, PhD, Director, Duke Institute for Genome Sciences
    & Policy's Center for Genomic Medicine, Duke University
  - Moti L. Kashyap, MD, Director, Atherosclerosis Research Center, VA
    Medical Center, Professor of Medicine, University of California, Irvine
  - Roger Longman, Managing Partner, Windhover Information
  - Sam Malik, Managing Partner, Strategyx
  - Mark Moran, MD, MBA, Chief Medical Officer, Synosis Therapeutics
  - Roger S. Newton, MD, Senior Vice President & Director, Esperion
    Therapeutics, Division of Pfizer Global R&D
  - Gary Palmer, MD, MBA, MPH, Senior Director of Medical Affairs, Genomic
    Health
  - Luis A. Parodi, PhD, Senior Director and Site Head, Clinical
    Pharmacogenomics, Pfizer
  - Dr. Michael A. Perelman, PhD, Clinical Associate Professor of
    Psychiatry, Reproductive Medicine, and Urology, Weill Medical College of
    Cornell University; Co-Director of the Human Sexuality Program, Payne
    Whitney Clinic of the New York Presbyterian Hospital; Senior Consulting
    Psychologist/Sex Therapist at the NY Center for Human Sexuality,
    Department of Urology, Columbia Presbyterian Medical Center; Senior
    Consulting Sex Therapist to the Department of Urology, Greenwich
    Hospital
  - Jorge Plutzky, MD, Director, The Vascular Disease Prevention Program,
    Brigham and Women's Hospital
  - Tony Rosenberg, BSc, MSc, Head of Global Business Development &
    Licensing, Novartis Pharma AG
  - David Seo, MD, Assistant Professor, Cardiology, Duke University
  - Thomas C. Seoh, JD, Chief Executive Officer, Faust Pharmaceuticals SA
  - Henry van den Berg, MD, Marketing Director for Enablex & Intrinsa, N.A.
    Strategic Planning, Procter & Gamble Pharmaceuticals

Therapeutic Insight 2007 is sponsored by Defined Health and Communitech Market Intelligence. An early registration discount is available until February 15, 2007. To register, or for more information, please visit http://www.therapeuticinsight.com/, or contact Communitech: (914) 245-7764, http://www.cmius.com/, or Defined Health: (973) 292-5001, http://www.definedhealth.com/.

  Contact:
  Ginny E. Llobell
  Vice President
  Defined Health
  973-292-5001